Alonso MD, Llorca J, Martinez-Vazquez F, Miranda-Filloy JA, Diaz de Teran T, Dierssen T, Vazquez-Rodriguez TR, Gomez-Acebo I, Blanco R, Gonzalez-Gay MA. Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study.
Medicine (Baltimore)  2011; 90: 350-358  F.I.: 4,256

Álvarez Rodríguez L, López-Hoyos M, Mata C, Fontalba A, Calvo Alen J, Marín MJ, Fernández-Luna JL, Aguero Balbín J, Aranzamendi Zaldunbide M, Blanco R, Martínez-Taboada VM. Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis.
Ann. Rheum. Dis.  2011; 70: 1677-1683  F.I.: 9,082

Alvarez-Rodriguez L, López-Hoyos M, Beares I, Mata C, Garcia-Unzueta M, Calvo-Alen J, Blanco R, Aurrecoechea E, Tripathi G, Martinez-Taboada VM. Toll-like receptor 4 gene polymorphisms in polymyalgia rheumatica and elderly-onset rheumatoid arthritis.
Clin. Exp. Rheumatol.  2011; 29: 795-800  F.I.: 2,358

Alvarez-Rodriguez L, Lopez-Hoyos M, Beares I, Muñoz Cacho P, Mata C, Calvo-Alen J, Corrales A, Tripathi G, Blanco R, Garcia-Unzueta M, Villa I, Martinez-Taboada VM. Lack of association between Toll-like receptor 4 gene polymorphisms and giant cell arteritis.
RHEUMATOLOGY  2011; 50: 1562-1568  F.I.: 4,171

Alvarez-Rodriguez L, Muñoz Cacho P, Lopez-Hoyos M, Beares I, Mata C, Calvo-Alen J, Villa I, Martinez-Taboada VM. Toll-like receptor 4 gene polymorphism and giant cell arteritis susceptibility: a cumulative meta-analysis.
Autoimmun. Rev.  2011; 10: 790-792  F.I.: 6,556

Amoli MM, Miranda-Filloy JA, Vazquez-Rodriguez TR, Ollier WE, Gonzalez-Gay MA. Interleukin-1 beta gene polymorphism in patients with biopsy-proven erythema nodosum.
Clin. Exp. Rheumatol.  2011; 29: 0-0  F.I.: 2,358

Amor-Dorado JC, Barreira-Fernandez MP, Vazquez-Rodriguez TR, Gomez-Acebo I, Miranda-Filloy JA, Diaz de Teran T, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with ankylosing spondylitis.
Medicine (Baltimore)  2011; 90: 99-109  F.I.: 4,256

Amor-Dorado JC, Barreira-Fernández MP, Vázquez-Rodríguez TR, Miranda-Filloy JA, Llorca J, González-Gay MA. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in ankylosing spondylitis.
Otol. Neurotol.  2011; 32: 278-283  F.I.: 2,065

Bretones G, Acosta JC, Caraballo JM, Ferrándiz N, Gómez-Casares MT, Albajar M, Blanco R, Ruiz P, Hung WC, Albero MP, Perez-Roger I, León J. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.
J. Biol. Chem.  2011; 286: 9815-9825  F.I.: 5,328

Carmona FD, Serrano A, Rodríguez-Rodríguez L, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Solans R, Sopeña B, Marí-Alfonso B, Unzurrunzaga A, Ortego-Centeno N, Blanco R, de Miguel E, Hidalgo-Conde A, Martín J, González-Gay MA. A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis.
J. Rheumatol.  2011; 38: 2598-2601  F.I.: 3,551

Carmona FD, Serrano-Lopera A, López-Isac E, Simeón CP, Carreira P, Rios-Fernandez R, Espinosa G, Camps MT, Navarrete N, González-Escribano MF, Vicente-Rabaneda E, Rodríguez-Rodríguez L, Tolosa C, Beltrán E, Gómez-Garcia I, Fernández-Castro M, López-Longo FJ, García-Hernández FJ, Castellví I, Trapiella L, Fernández-Nebro A, García-Portales R, Egurbide MV, Fonollosa V, García de la Peña P, Pros A, Rodríguez-Carballeira M, Díaz-Gónzalez F, Sáez-Comet L, González-Gay MA, Martín J. No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis.
Clin. Exp. Rheumatol.  2011; 29: 895-896  F.I.: 2,358

Carmona FD, Simeon CP, Beretta L, Carreira P, Vonk MC, Ríos-Fernández R, Espinosa G, Navarrete N, Vicente-Rabaneda E, Rodríguez-Rodríguez L, Tolosa C, García-Hernández FJ, Castellví I, Egurbide MV, Fonollosa V, González-Gay MA, Rodríguez-Carballeira M, Díaz-Gónzalez F, Sáez-Comet L, Hesselstrand R, Riemekasten G, Witte T, Voskuyl AE, Schuerwegh AJ, Madhok R, Shiels P, Fonseca C, Denton C, Nordin A, Palm Ø, Hoffmann-Vold AM, Airó P, Scorza R, Lunardi C, van Laar JM, Hunzelmann N, Kreuter A, Herrick A, Worthington J, Koeleman BP, Radstake TR, Martín J. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis.
Ann. Rheum. Dis.  2011; 70: 2050-2052  F.I.: 9,082

Docampo E, Giardina E, Riveira-Muñoz E, de Cid R, Escaramís G, Perricone C, Fernández-Sueiro JL, Maymó J, González-Gay MA, Blanco FJ, Hüffmeier U, Lisbona MP, Martín J, Carracedo A, Reis A, Rabionet R, Novelli G, Estivill X. Deletion of LCE3C and LCE3B is a susceptibility factor for psoriatic arthritis: a study in Spanish and Italian populations and meta-analysis.
Arthritis Rheum.  2011; 63: 1860-1865  F.I.: 8,435

García-Bermúdez M, González-Juanatey C, Rodríguez-Rodríguez L, Miranda-Filloy JA, Perez-Esteban S, Vazquez-Rodriguez TR, Castañeda S, Balsa A, Fernández-Gutierrez B, Llorca J, González-Alvaro I, Martín J, González-Gay MA. Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis.
Clin. Exp. Rheumatol.  2011; 29: 681-688  F.I.: 2,358

García-Bermúdez M, González-Juanatey C, Rodríguez-Rodríguez L, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernández-Gutierrez B, Llorca J, Martin J, González-Gay MA. Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis.
Clin. Exp. Rheumatol.  2011; 29: 293-298  F.I.: 2,358

Gonzalez-Gay MA, Gonzalez-Juanatey C, Llorca J. Subclinical atherosclerosis in ankylosing spondylitis.
J. Rheumatol.  2011; 38: 2073-0  F.I.: 3,551

Gonzalez-Gay MA, Gonzalez-Juanatey C, Miranda-Filloy JA, Martin J, Garcia-Unzueta MT, Llorca J. Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'.
Arthritis Res. Ther.  2011; 13: 404-0  F.I.: 4,357

Gonzalez-Gay MA, Gonzalez-Juanatey C, Rodriguez-Rodriguez L, Miranda-Filloy JA, Martin J, Llorca J. Lack of association between adipokines and ghrelin and carotid intima-media thickness in patients with severe rheumatoid arthritis.
Clin. Exp. Rheumatol.  2011; 29: 358-359  F.I.: 2,358

González-Juanatey C, Llorca J, González-Gay MA. Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease.
Arthritis Res. Ther.  2011; 13: 0-0  F.I.: 4,357

González-López MA, González-Vela MC, Salas-Venero CA, Conde R, Val-Bernal JF. Cutaneous infection caused by Nocardiopsis dassonvillei presenting with sporotrichoid spread.
J. Am. Acad. Dermatol.  2011; 65: 0-0  F.I.: 4,274

González-López MA, González-Vela MC, Yáñez S, Fernández-Llaca H, Val-Bernal JF. Psoriasiform skin eruption associated with sorafenib therapy.
Indian J. Dermatol. Venereol. Leprol.  2011; 77: 614-615  F.I.: 0,932

Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M, Diaz-Gallo LM, Broen JC, Vonk MC, Simeon CP, Alizadeh BZ, Coenen MJ, Voskuyl AE, Schuerwegh AJ, van Riel PL, Vanthuyne M, van 't Slot R, Italiaander A, Ophoff RA, Hunzelmann N, Fonollosa V, Ortego-Centeno N, González-Gay MA, García-Hernández FJ, González-Escribano MF, Airo P, van Laar J, Worthington J, Hesselstrand R, Smith V, de Keyser F, Houssiau F, Chee MM, Madhok R, Shiels PG, Westhovens R, Kreuter A, de Baere E, Witte T, Padyukov L, Nordin A, Scorza R, Lunardi C, Lie BA, Hoffmann-Vold AM, Palm O, García de la Peña P, Carreira P, Varga J, Hinchcliff M, Lee AT, Gourh P, Amos CI, Wigley FM, Hummers LK, Nelson JL, Riemekasten G, Herrick A, Beretta L, Fonseca C, Denton CP, Gregersen PK, Agarwal S, Assassi S, Tan FK, Arnett FC, Radstake TR, Mayes MD, Martin J. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.
PLoS Genet.  2011; 7: 0-0  F.I.: 9,543

Ide MR, Gonzalez-Gay MA, Yano KC, Imai MJ, de Andrade MC, Llorca J. Functional capacity in rheumatoid arthritis patients: comparison between Spanish and Brazilian sample.
Rheumatol. Int.  2011; 31: 221-226  F.I.: 1,431

Kremer JM, Blanco R, Brzosko M, Burgos-Vargas R, Halland AM, Vernon E, Ambs P, Fleischmann R. Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year.
Arthritis Rheum.  2011; 63: 609-621  F.I.: 8,435

López-Mejías R, García-Bermúdez M, González-Juanatey C, Castañeda S, Miranda-Filloy JA, Gómez-Vaquero C, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, Blanco R, González-Álvaro I, Llorca J, Martín J, González-Gay MA. Lack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis.
Tissue Antigens  2011; 78: 438-441  F.I.: 3,024

López-Mejías R, García-Bermúdez M, González-Juanatey C, Castañeda S, Pérez-Esteban S, Miranda-Filloy JA, Gómez-Vaquero C, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, Blanco R, González-Álvaro I, Llorca J, Martín J, González-Gay MA. Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis.
Atherosclerosis  2011; 219: 655-658  F.I.: 4,086

Martín JE, Alizadeh BZ, González-Gay MA, Balsa A, Pascual-Salcedo D, González-Escribano MF, Rodriguez-Rodriguez L, Fernández-Gutiérrez B, Raya E, Coenen MJ, van Riel P, Radstake TR, Kvien TK, Viken MK, Lie BA, Koeleman BP, Martín J. Evidence for PTPN22 R620W polymorphism as the sole common risk variant for rheumatoid arthritis in the 1p13.2 region.
J. Rheumatol.  2011; 38: 2290-2296  F.I.: 3,551

Martinez-Lado L, Calviño-Díaz C, Piñeiro A, Dierssen T, Vazquez-Rodriguez TR, Miranda-Filloy JA, Lopez-Diaz MJ, Blanco R, Llorca J, Gonzalez-Gay MA. Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain.
Medicine (Baltimore)  2011; 90: 186-193  F.I.: 4,256

Perez-Ruiz F, Carmona L, Yébenes MJ, Pascual E, de Miguel E, Ureña I, González-Gay MA. An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study.
JCR-J. Clin. Rheumatol.  2011; 17: 349-355  F.I.: 1,283

Rodríguez-Rodríguez L, Carmona FD, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Marí-Alfonso B, Gómez-Vaquero C, Amigo-Díaz E, Ríos-Fernández R, Blanco R, Llorca J, Fernández-Gutiérrez B, Martín J, González-Gay MA. Role of rs1343151 IL23R and rs3790567 IL12RB2 polymorphisms in biopsy-proven giant cell arteritis.
J. Rheumatol.  2011; 38: 889-892  F.I.: 3,551

Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Gómez-Vaquero C, Marí-Alfonso B, Miranda-Filloy JA, Narvaez J, Ortego-Centeno N, Vicente EF, Blanco R, Amigo-Diaz E, Fernández-Gutiérrez B, Martin J, González-Gay MA. Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis.
Clin. Exp. Rheumatol.  2011; 29: 0-0  F.I.: 2,358

Rodriguez-Rodriguez L, Garcia-Bermudez M, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA. Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients.
Clin. Exp. Rheumatol.  2011; 29: 19-25  F.I.: 2,358

Rodríguez-Rodríguez L, García-Bermúdez M, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA. Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis.
Clin. Exp. Rheumatol.  2011; 29: 142-143  F.I.: 2,358

Rodríguez-Rodríguez L, García-Bermúdez M, González-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, González-Gay MA. Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients.
Tissue Antigens  2011; 77: 74-78  F.I.: 3,024

Rodríguez-Rodríguez L, García-Bermúdez M, González-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernández-Gutierrez B, Llorca J, Martín J, González-Gay MA. Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients.
Tissue Antigens  2011; 77: 291-297  F.I.: 3,024

Rodríguez-Rodríguez L, González-Juanatey C, García-Bermúdez M, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA. CCR5?32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study.
Arthritis Res. Ther.  2011; 13: 0-0  F.I.: 4,357

Rodríguez-Rodríguez L, González-Juanatey C, Palomino-Morales R, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis.
Atherosclerosis  2011; 216: 125-130  F.I.: 4,086

Teruel M, Martin JE, González-Juanatey C, López-Mejias R, Miranda-Filloy JA, Blanco R, Balsa A, Pascual-Salcedo D, Rodriguez-Rodriguez L, Fernández-Gutierrez B, Ortiz AM, González-Alvaro I, Gómez-Vaquero C, Bottini N, Llorca J, González-Gay MA, Martin J. Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients.
Arthritis Res. Ther.  2011; 13: 0-0  F.I.: 4,357